Copeptin Testing in Acute Myocardial Infarction: Ready for Routine Use?

Copeptin Testing in Acute Myocardial Infarction: Ready for Routine Use?

Suspected acute myocardial infarction is one of the leading causes of admission to emergency departments. In the last decade, biomarkers revolutionized the management of patients with suspected acute coronary syndromes. Besides their pivotal assistance in timely diagnosis, biomarkers provide additio...

Full description

Bibliographic Details
Main Authors:	Sebastian Johannes Reinstadler, Gert Klug, Hans-Josef Feistritzer, Bernhard Metzler, Johannes Mair
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Disease Markers
Online Access:	http://dx.doi.org/10.1155/2015/614145

Similar Items

SIGNIFICANCE OF COPEPTIN IN DIAGNOSTICS OF MYOCARDIAL INFARCTION
by: L. V. Kremneva
Published: (2017-12-01)

Biomarkers of Hemodynamic Stress and Aortic Stiffness after STEMI: A Cross-Sectional Analysis
by: Sebastian Johannes Reinstadler, et al.
Published: (2015-01-01)

Complete versus simplified Selvester QRS score for infarct severity assessment in ST-elevation myocardial infarction
by: Christina Tiller, et al.
Published: (2019-12-01)

The incremental value of combination copeptin and troponin T for early diagnosis of acute myocardial infarction
by: Daniel R Mulyono, et al.
Published: (2013-06-01)

Role of Cardiac Magnetic Resonance to Improve Risk Prediction following Acute ST-elevation Myocardial Infarction
by: Martin Reindl, et al.
Published: (2020-04-01)

Combined measurements of plasma copeptin and troponin-I levels for early exclusion of acute myocardial infarction
by: Walid Omar Ahmed, et al.
Published: (2016-12-01)

Copeptin and NTproBNP in patients with acute Q - myocardial infarction complicated by acute heart failure with hyperglycemia on admission
by: Victor Syvolap, et al.
Published: (2019-05-01)

44. Copeptin as early marker of acute non-ST elevation myocardial infarction in patients suspected with acute coronary syndrome
by: S. Rafla, et al.
Published: (2016-07-01)

Cardiac high-energy phosphate metabolism alters with age as studied in 196 healthy males with the help of 31-phosphorus 2-dimensional chemical shift imaging.
by: Regina Esterhammer, et al.
Published: (2014-01-01)

Association between copeptin and contrast-induced nephropathy in patients with ST-elevation myocardial infarction
by: Ersin Yildirim, et al.
Published: (2019-12-01)

Association between copeptin and contrast-induced nephropathy in patients with ST-elevation myocardial infarction
by: Ersin Yildirim, et al.
Published: (2019-12-01)

Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance
by: Klug Gert, et al.
Published: (2012-07-01)

Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity.
by: Hans-Josef Feistritzer, et al.
Published: (2015-01-01)

Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction
by: Müller Silvana, et al.
Published: (2009-07-01)

Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke.
by: Felix Fluri, et al.
Published: (2012-01-01)

Gender features of structural and functional changes of the heart and levels of copeptin and NTproBNP in patients with acute Q-myocardial infarction in the presence of pulmonary hypertension
by: V. D. Syvolap, et al.
Published: (2021-07-01)

Combined determination of highly sensitive troponin T and copeptin for early exclusion of acute myocardial infarction: first experience in an emergency department of a general hospital
by: Lotze U, et al.
Published: (2011-08-01)

Impact of Morphine Treatment on Infarct Size and Reperfusion Injury in Acute Reperfused ST-Elevation Myocardial Infarction
by: Ingo Eitel, et al.
Published: (2020-03-01)

Impact of copeptin on diagnosis of acute coronary syndrome
by: Zeinab H. El Sayed, et al.
Published: (2014-07-01)

Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction
by: Sebastian J. Reinstadler, et al.
Published: (2020-07-01)

Relationship between levels of Copeptin, NTproBNP and structural functional parameters of the heart in patients with acute myocardial infarction with ST-segment elevation complicated by pulmonary hypertension
by: Victor Syvolap, et al.
Published: (2020-02-01)

Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis.
by: Hyungoo Shin, et al.
Published: (2018-01-01)

A comparative study of rapid test and routine methods for the measurement of cardiac markers in patients with suspected acute myocardial infarction
by: gholamreza Shahsavari, et al.
Published: (2014-06-01)

Clinical role of serum Copeptin in acute coronary syndrome
by: Manal Abd El Baky Mahmoud, et al.
Published: (2018-09-01)

Copeptin: Limited Usefulness in Early Stroke Differentiation?
by: Johannes von Recum, et al.
Published: (2015-01-01)

Copeptin in anorexia nervosa
by: Jens P. Goetze, et al.
Published: (2020-04-01)

Copeptin in heart failure
by: Lasota B, et al.
Published: (2014-07-01)

Acute myocardial infarction
by: De la Vega-Vélez Henrique
Published: (2012-12-01)

Copeptin for risk stratification in acute illness: beyond cardiological problems
by: Roberto Cemin, et al.
Published: (2013-10-01)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
by: Rosa Zampino, et al.
Published: (2021-01-01)

Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage
by: Merlo Adrian, et al.
Published: (2010-05-01)

High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS
by: Diana Hernández-Romero, et al.
Published: (2012-01-01)

Acute myocardial infarction in myocardial revascularization
by: Dr. Karel Morlans Hernández, et al.
Published: (2014-03-01)

The value of routine blood test parameters obtained at admission to predict acute stent thrombosis in patients with st-segment elevation myocardial infarction
by: Yusuf Cekici
Published: (2020-12-01)

Is there enough evidence for routine use of drug-eluting stents in acute myocardial infarction with ST segment elevation?
by: Tešić Milorad, et al.
Published: (2014-01-01)

Estimating the extent of myocardial damage in patients with STEMI using the DETERMINE score
by: Christina Tiller, et al.
Published: (2021-06-01)

Correlation between serum Copeptin and myocardial damage degree as well as RAAS system activation in patients with acute coronary syndrome (ACS)
by: Jing-Wen Xia
Published: (2017-04-01)

Arginine vasopressin and copeptin in perinatology
by: Katrina Suzanne Evers, et al.
Published: (2016-08-01)

The Rise and Fall of Routine Manual Thrombectomy for ST-Elevation Myocardial Infarction
by: Vincent Floré, et al.
Published: (2016-04-01)

The use of the biomarker “copeptin” for the diagnosis of acute chest pain in the Emergency Department
by: Elisa Conti, et al.
Published: (2011-09-01)

Cannot write session to /tmp/vufind_sessions/sess_ormgbmbtvsbsomoitf2gqm6u5t